Lot Disposition; A Thorough Review and Comparison of the Latest Regulatory Expectations Governing and Controlling Lot Disposition in US, Canada and the EU

Live, Interactive Training Webinar

Date: Tuesday August 20, 2019 - Time: 10:30am - 12:30pm ET (New York Time)
Instructor: Peter Calcott Ph.D. Biography>>>

Member Registration ►

Registration Form ►

Disposition and release of materials from plants, whether they be your own facilities or those of your contract manufacturers, is a key step in the process of manufacture of product to fuel your clinical trial or your commercial sales and marketing groups. There is always continuous pressure to release materials earlier but this must be weighed against the risks of making a rash or wrong decision in the disposition process. A poor decision can result in Field Alerts or Biological Deviation Reports or even recalls. With the increased vigilance of the agencies worldwide and the tightening requirements, it is important that your processes be efficient, compliant yet efficient and flexible to meet these apparently opposing forces. Even the most robust system can always see opportunity for improvement in speed and decreased risk if the correct questions are posed and then answered effectively. Based on warning letters in 2013, many companies still run foul of the law in their processes and it is becoming more of a focus for the agencies.

This live training webinar will provide valuable information on the requirements for lot disposition as defined by the regulations in USA, Canada and the EU. This will enable you to see how successful companies can translate these requirements into workable processes that are compliant with the regulations and yet efficient from a business perspective. Elements of risk management will be discussed as they pertain to development and execution of a system for lot disposition for clinical as well as commercial products for products manufactured within your own plants as well as those manufactured in your contract manufacturer's facilities. The webinar will present some metrics that can be put into place to measure your performance versus expectations which will set you on the road to continuous improvement. With this information you will be able to benchmark against some successful companies. You will also see how companies run foul of the agencies resulting in warning letters and how from this information you will be able to assure that you do not suffer the same fate.

Learning Benefits:
-The requirements for lot disposition.
-What FDA and international regulations govern lot disposition.
-How to assemble and review the raw data and information and make rational decisions.
-How to incorporate risk management into the disposition process so you can focus your resources in the most vulnerable areas.
-The different challenges and how to manage them with clinical trial materials versus commercial products.
-What the agencies expect from you to convince them you are in compliance and in control.
-How to manage contract manufacturers and the release of materials.
-Where companies go wrong and get into regulatory hot water and how to avoid it yourself.

Regulations that will be Covered:
Each country has its own specific sets of regulations. Below are citations from ICH and examples of regulations that are applicable to the inspection and response processes and philosophy:
Code of Federal Regulations 21 sections 210, 211 for Biological products and Drugs and 600 series for Biologicals in addition for USA.
EMA Eudralex Volumes 1, 2, 3, 4, 9 for Drugs and Biologics in EU.
International Conference on Harmonization Quality Series Q1 through Q10 for USA, EU, Japan and other countries with an emphasis on ICH Q7a.

Webinar outline and time breakdown:

10:15 AM Log In Period
10:30 AM Introduction
10:40 AM The elements of disposition of materials,
The regulations governing and controlling lot disposition,
How to compile and review data and information,
Making risk based decisions - balancing commercial and compliance issues,
Understanding what to delegate and what to control,
11:30 AM Break
11:40 AM Certificate of Analysis and Certificate of Compliance,
Dispositioning materials for clinical versus commerce,
Metrics associated with the disposition process,
Managing contract manufacturers and releasing materials,
Where companies go wrong and how to avoid their problems,
12:30 PM Live Questions & Discussion

*Please note all times are Eastern Time (New York Time)

This live training webinar includes the following for each registered attendee:

  • A copy of the presentation slides
  • A certificate of participation for attendee training records

Who should attend:
The following individuals or disciplines will benefit from attending this Webinar:

  • Senior management
  • Quality Assurance personnel and management
  • Quality Control personnel and management
  • Compliance auditors and management
  • Manufacturing management and scientists
  • Supply Chain and Logistics managers
  • Regulatory Affairs Professionals
  • Project Managers working in the CMC arena

Registration Form ►

Instructor: Peter Calcott Ph.D.

Peter H. Calcott, Ph.D. is President, Calcott Consulting which is focused on delivering solutions to pharmaceutical and biotechnology companies in the areas of corporate strategy, supply chain, quality, clinical development, regulatory affairs, corporate compliance and enterprise e-solutions. He is also an Academic Program Developer for the University of California, Berkeley’s Biotechnology and Pharmaceutics Postgraduate Programs. Prior to this he was VP at the executive team level at PDL BioPharma where he was responsible for development and implementation of Quality & Compliance strategy across the corporation… Full Bio>>>



Course Number: 309

System Requirements:

All Pharma Webinars live training programs audio and visual are delivered via Cisco WebEx with basic system requirements of a computer with internet access and a telephone to access the audio portion of the presentations. You can choose to access the audio through your computer.

Live Training Benefits:

• Pharma Webinars training webinars and programs are presented exclusively as live events only.

• Designed and delivered based on e-learning best practices, Pharma Webinars' live training webinars and programs are as effective as in person training.

• Live training webinars and multi-part training programs are strictly educational based, and do not promote or endorse any products or services whatsoever.

• An interactive live Q&A and discussion period is included in each live training presentation. Questions can also be submitted to the speaker via email both prior to and following the live training webinar as a means of improving participant experience, and ensuring successful topic comprehension.

• Live presentations ensure that all live training webinars and programs are engaging and informative, allowing trainees to exchange ideas through audio conferencing and live chat during each presentation in real time. Each live training session includes a dedicated live Q&A period allowing trainees to interact directly with the instructor, with quick feedback providing them with concrete understanding of the answers and the training subject itself.

• Each Pharma Webinars live training webinar and program content is updated on regular basis to provide the latest regulatory, operational and technological trends in the international pharmaceutical arena. As regulatory expectations, guidance, or industry trends change, so does our training in order to reflect those changes as soon as the changes are released.

• Pharma Webinars' instructors are the most recognized subject matter experts in the industry who are selected based on very strict qualification criteria. They are coached on the latest e-learning speaking methods in order to make each presentation engaging, memorable and very effective.

• Each registered attendee receives an exact copy of the presentation slides and other course handouts significantly reducing the learning curve as trainees can refer back to this material in the future.

• All trainees receive a Certificate of Attendance for each live training webinar and program they attend to be kept for training records.

Client Testimonials:

"The live webinar was very useful to our team, the content was relevant and the instructor was very knowledgeable" QC Microbiology Supervisor, NJ

"We were very satisfied with the live presentation; we appreciated the speaker staying on to answer all of our questions" QA Director, MA

"Our group enjoyed the live presentation and found the experience much more engaging and worthwhile than any recorded webcasts" Sr Training Manager, CA

"This was my first live training, I found it easy to connect, participate and very useful" Laboratory Analyst, PA

"We had our entire department attend this training program and found it to be very useful, I am very satisfied with the speaker's ability to keep the audience engaged" QC Manager, NY

"Given how recent the content of the webinar was, our team members were very happy with the relevance of the training" VP Clinical Operations, CA

"Is my first time to attend training, I enjoy it very much" Sr Manager, Korea

"Our department found the level of interactivity between the audience and the instructor far beyond that of any other online training that we have attended before. Well done" Director Regulatory Affairs, ON

"Our interest group was spread out over three locations and we were able to participate simultaneously and interact very easily" Lead Compliance Manager, IL

"Well satisfied with the presentation. Our team found the speaker's level of knowledge and his ability to translate that knowledge to our processes very valuable" VP Quality Operations, NC

"We were impressed with the quality of the presentation, and despite our being located in Europe we were able to participate without a hitch" QC Manager, Ireland